These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 18583311

  • 1. Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms.
    Walsh MF, Ampasala DR, Hatfield J, Vander Heide R, Suer S, Rishi AK, Basson MD.
    Am J Pathol; 2008 Aug; 173(2):385-99. PubMed ID: 18583311
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Harling J, Gaster L, Callahan JF, Olson BA.
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
    Wendt MK, Schiemann WP.
    Breast Cancer Res; 2009 Jul; 11(5):R68. PubMed ID: 19740433
    [Abstract] [Full Text] [Related]

  • 4. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
    Ungefroren H, Sebens S, Groth S, Gieseler F, Fändrich F.
    Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
    [Abstract] [Full Text] [Related]

  • 5. Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma.
    Ghosh AK, Wei J, Wu M, Varga J.
    Biochem Biophys Res Commun; 2008 Sep 19; 374(2):231-6. PubMed ID: 18627765
    [Abstract] [Full Text] [Related]

  • 6. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle.
    Dadlani H, Ballinger ML, Osman N, Getachew R, Little PJ.
    J Biol Chem; 2008 Mar 21; 283(12):7844-52. PubMed ID: 18223258
    [Abstract] [Full Text] [Related]

  • 7. Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor.
    Burch ML, Ballinger ML, Yang SNY, Getachew R, Itman C, Loveland K, Osman N, Little PJ.
    J Biol Chem; 2010 Aug 27; 285(35):26798-26805. PubMed ID: 20571025
    [Abstract] [Full Text] [Related]

  • 8. Role of ALK5/Smad2/3 and MEK1/ERK Signaling in Transforming Growth Factor Beta 1-modulated Growth, Collagen Turnover, and Differentiation of Stem Cells from Apical Papilla of Human Tooth.
    Chang HH, Chang MC, Wu IH, Huang GF, Huang WL, Wang YL, Lee SY, Yeh CY, Guo MK, Chan CP, Hsien HC, Jeng JH.
    J Endod; 2015 Aug 27; 41(8):1272-80. PubMed ID: 26001858
    [Abstract] [Full Text] [Related]

  • 9. Focal adhesion kinase signaling determines the fate of lung epithelial cells in response to TGF-β.
    Ding Q, Subramanian I, Luckhardt TR, Che P, Waghray M, Zhao XK, Bone N, Kurundkar AR, Hecker L, Hu M, Zhou Y, Horowitz JC, Vittal R, Thannickal VJ.
    Am J Physiol Lung Cell Mol Physiol; 2017 Jun 01; 312(6):L926-L935. PubMed ID: 28360109
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
    Shinto O, Yashiro M, Kawajiri H, Shimizu K, Shimizu T, Miwa A, Hirakawa K.
    Br J Cancer; 2010 Mar 02; 102(5):844-51. PubMed ID: 20145621
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.
    Yakymovych I, Engström U, Grimsby S, Heldin CH, Souchelnytskyi S.
    Biochemistry; 2002 Sep 10; 41(36):11000-7. PubMed ID: 12206672
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-β1 induces type II collagen and aggrecan expression via activation of extracellular signal-regulated kinase 1/2 and Smad2/3 signaling pathways.
    Zhu Y, Tao H, Jin C, Liu Y, Lu X, Hu X, Wang X.
    Mol Med Rep; 2015 Oct 10; 12(4):5573-9. PubMed ID: 26165845
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation.
    You HJ, Bruinsma MW, How T, Ostrander JH, Blobe GC.
    Carcinogenesis; 2007 Dec 10; 28(12):2491-500. PubMed ID: 17768179
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Smad2 is involved in Aggregatibacter actinomycetemcomitans-induced apoptosis.
    Yoshimoto T, Fujita T, Ouhara K, Kajiya M, Imai H, Shiba H, Kurihara H.
    J Dent Res; 2014 Nov 10; 93(11):1148-54. PubMed ID: 25192897
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.